PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26018524-11	2015	The ERBB2 inhibitor TAK-165 was synergistic with trametinib in KRAS-mutant cell lines.	TAK-165	20-27	KRAS proto-oncogene, GTPase	Homo sapiens	63-67